Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 119.
A
Abbosh, C;
Swanton, C;
Birkbak, NJ;
(2018)
Circulating tumor DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer.
Annals of Oncology
10.1093/annonc/mdy017.
(In press).
|
 |
|
Abdollah, MRA;
Carter, TJ;
Jones, C;
Kalber, TL;
Rajkumar, V;
Tolner, B;
Gruettner, C;
... Chester, KA; + view all
(2018)
Fucoidan Prolongs the Circulation Time of Dextran-Coated Iron Oxide Nanoparticles.
ACS Nano
, 12
(2)
pp. 1156-1169.
10.1021/acsnano.7b06734.
|
|
Abou-Alfa, G;
Qin, S;
Ryoo, B-Y;
Lu, S-N;
Yen, C-J;
Feng, Y-H;
Lim, HY;
... Chen, L-T; + view all
(2018)
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma.
Annals of Oncology
, 29
(6)
pp. 1402-1408.
10.1093/annonc/mdy101.
|
|
Abou-Alfa, GK;
Meyer, T;
Cheng, A-L;
El-Khoueiry, AB;
Rimassa, L;
Ryoo, B-Y;
Cicin, I;
... Kelley, RK; + view all
(2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
New England Journal of Medicine
, 379
(1)
pp. 54-63.
10.1056/NEJMoa1717002.
|
|
Adams, R;
Brown, E;
Brown, L;
Butler, R;
Falk, S;
Fisher, D;
Kaplan, R;
... FOCUS4 Trial Investigators; + view all
(2018)
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial.
The Lancet Gastroenterology & Hepatology
, 3
(3)
pp. 162-171.
10.1016/S2468-1253(17)30394-1.
|
|
|
Agerbæk, MØ;
Bang-Christensen, SR;
Yang, M-H;
Clausen, TM;
Pereira, MA;
Sharma, S;
Ditlev, SB;
... Salanti, A; + view all
(2018)
The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner.
Nature Communications
, 9
(1)
, Article 3279. 10.1038/s41467-018-05793-2.
|
|
|
Alexandrou, C;
Al-Aqbi, SS;
Higgins, JA;
Boyle, W;
Karmokar, A;
Andreadi, C;
Luo, J-L;
... Rufini, A; + view all
(2018)
Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.
Scientific Reports
, 8
, Article 12096. 10.1038/s41598-018-30591-7.
|
|
|
Alrifai, D;
Forster, MD;
Janes, SM;
(2018)
Emerging resistance pathways in lung cancer: what has ROS-1 taught us?
[Editorial comment].
Translational Lung Cancer Research
, 7
(Suppl 1)
S9-S12.
10.21037/tlcr.2017.11.13.
|
|
|
Arkenau, H-T;
Italiano, A;
Mak, G;
Toulmonde, M;
Baird, RD;
Garcia-Corbacho, J;
Plummer, R;
... Spicer, J; + view all
(2018)
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours.
European Journal of Cancer
, 103
pp. 17-23.
10.1016/j.ejca.2018.07.134.
|
|
Attard, G;
Borre, M;
Gurney, H;
Loriot, Y;
Andresen-Daniil, C;
Kalleda, R;
Trinh, P;
(2018)
Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment.
Journal of Clinical Oncology
, 36
(25)
pp. 2639-2646.
10.1200/JCO.2018.77.9827.
|
|
B
|
Bakhoum, SF;
Ngo, B;
Laughney, AM;
Cavallo, J-A;
Murphy, CJ;
Ly, P;
Shah, P;
... Cantley, LC; + view all
(2018)
Chromosomal instability drives metastasis through a cytosolic DNA response.
Nature
, 553
(7689)
pp. 467-472.
10.1038/nature25432.
|
|
|
Barata, PC;
De Liano, AG;
Mendiratta, P;
Crolley, V;
Szabados, B;
Morrison, L;
Wood, L;
... Rini, BI; + view all
(2018)
The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma.
British Journal of Cancer
, 119
(2)
pp. 160-163.
10.1038/s41416-018-0104-z.
|
|
|
Belderbos, BPSI;
de Wit, R;
Chien, C;
Mitselos, A;
Hellemans, P;
Jiao, J;
Yu, MK;
... Saad, F; + view all
(2018)
An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer.
Cancer Chemotherapy and Pharmacology
, 82
(3)
pp. 457-468.
10.1007/s00280-018-3632-6.
|
|
|
Bird, TG;
Müller, M;
Boulter, L;
Vincent, DF;
Ridgway, RA;
Lopez-Guadamillas, E;
Lu, W-Y;
... Forbes, SJ; + view all
(2018)
TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence.
Science Translational Medicine
, 10
(454)
, Article eaan1230. 10.1126/scitranslmed.aan1230.
|
|
|
Birley, K;
Chester, K;
Anderson, J;
(2018)
Antibody based therapy for childhood solid cancers.
Current Opinion in Chemical Engineering
, 19
pp. 153-162.
10.1016/j.coche.2018.01.005.
|
|
Blas, P;
Tolner, B;
Ward, J;
Chester, K;
Hoare, M;
(2018)
The use of a surface active agent in the protection of a fusion protein during bioprocessing.
Biotechnology and Bioengineering
, 115
(11)
pp. 2760-2770.
10.1002/bit.26817.
|
|
|
Böiers, C;
Richardson, SE;
Laycock, E;
Zriwil, A;
Turati, VA;
Brown, J;
Wray, JP;
... Enver, T; + view all
(2018)
A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1.
Developmental Cell
, 44
(3)
pp. 362-377.
10.1016/j.devcel.2017.12.005.
|
|
Brandner, SGP;
Jaunmuktane, Z;
Capper, D;
Jones, DTW;
Sill, M;
Hovestadt, V;
Schrimpf, D;
... Pfister, SM; + view all
(2018)
DNA methylation-based classification of central nervous system tumours.
Nature. International Journal of Science
, 555
pp. 469-474.
10.1038/nature26000.
|
|
Brown, NF;
Williams, M;
Arkenau, H-T;
Fleming, RA;
Tolson, J;
Yan, L;
Zhang, J;
... Mulholland, P; + view all
(2018)
A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [¹¹C]GSK2256098.
Neuro-Oncology
, 20
(12)
pp. 1634-1642.
10.1093/neuonc/noy078.
|
C
|
Capper, D;
Engel, NW;
Stichel, D;
Lechner, M;
Gloess, S;
Schmid, S;
Koelsche, C;
... Schueller, U; + view all
(2018)
DNA methylation-based reclassification of olfactory neuroblastoma.
Acta Neuropathologica
, 136
(2)
pp. 255-271.
10.1007/s00401-018-1854-7.
|
|
Casali, PG;
Bielack, S;
Abecassis, N;
Aro, HT;
Bauer, S;
Biagini, R;
Bonvalot, S;
... Blay, JY; + view all
(2018)
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology
, 29
(4)
pp. 79-95.
10.1093/annonc/mdy310.
|
|
|
Chakravarthy, A;
Furness, A;
Joshi, K;
Ghorani, E;
Ford, K;
Ward, MJ;
King, EV;
... Fenton, TR; + view all
(2018)
Author Correction: Pan-cancer deconvolution of tumour composition using DNA methylation.
[Corrigendum].
Nature Communications
, 9
, Article 4642. 10.1038/s41467-018-07155-4.
|
|
|
Chakravarthy, A;
Furness, A;
Joshi, K;
Ghorani, E;
Ford, K;
Ward, MJ;
King, EV;
... Fenton, TR; + view all
(2018)
Pan-cancer deconvolution of tumour composition using DNA methylation.
Nature Communications
, 9
, Article 3220. 10.1038/s41467-018-05570-1.
|
 |
|
Chen, L;
Esfandiari, A;
Reaves, W;
Vu, A;
Hogarty, MD;
Lunec, J;
Tweddle, DA;
(2018)
Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours.
International Journal of Oncology
, 52
(3)
pp. 967-977.
10.3892/ijo.2018.4261.
|
|
Cho, S;
Zammarchi, F;
Williams, DG;
Havenith, CE;
Monks, NR;
Tyrer, P;
d'Hooge, F;
... van Berkel, PH; + view all
(2018)
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-drug Conjugate Targeting PSMA, in Pre-clinical Models of Prostate Cancer.
Molecular Cancer Therapeutics
, 17
(10)
10.1158/1535-7163.MCT-17-0982.
|
|
Claus, J;
Patel, G;
Autore, F;
Colomba, A;
Weitsman, G;
Soliman, TN;
Roberts, S;
... Parker, PJ; + view all
(2018)
Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface.
eLIFE
, 7
, Article e32271. 10.7554/eLife.32271.
|
|
|
Conibear, J;
Chia, B;
Ngai, Y;
Bates, AT;
Counsell, N;
Patel, R;
Eaton, D;
... Landau, D; + view all
(2018)
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.
BMJ Open
, 8
(4)
, Article e020690. 10.1136/bmjopen-2017-020690.
|
|
|
Conteduca, V;
Scarpi, E;
Salvi, S;
Casadio, V;
Lolli, C;
Gurioli, G;
Schepisi, G;
... De Giorgi, U; + view all
(2018)
Plasma Androgen Receptor and Serum Chromogranin a in Advanced Prostate Cancer.
Scientific Reports
, 8
, Article 15442. 10.1038/s41598-018-33774-4.
|
|
|
Cope, AP;
Barnes, MR;
Belson, A;
Binks, M;
Brockbank, S;
Bonachela-Capdevila, F;
Carini, C;
... RA-MAP Consortium; + view all
(2018)
The RA-MAP Consortium: a working model for academia-industry collaboration.
Nature Reviews Rheumatology
, 14
(1)
pp. 53-60.
10.1038/nrrheum.2017.200.
|
D
|
Davda, R;
(2018)
Wnt signalling in prostate cancer stem-like cells.
Doctoral thesis (M.D(Res)), UCL (University College London).
|
|
|
Davidson, SM;
Riquelme, JA;
Zheng, Y;
Vicencio, JM;
Lavandero, S;
Yellon, DM;
(2018)
Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning.
Scientific Reports
, 8
, Article 15885. 10.1038/s41598-018-34357-z.
|
|
|
de Carcer, G;
Venkateswaran, SV;
Salgueiro, L;
El Bakkali, A;
Somogyi, K;
Rowald, K;
Montanes, P;
... Sotillo, R; + view all
(2018)
Plk1 overexpression induces chromosomal instability and suppresses tumor development.
Nature Communications
, 9
, Article 3012. 10.1038/s41467-018-05429-5.
|
|
|
Dillon, MT;
Boylan, Z;
Smith, D;
Guevara, J;
Mohammed, K;
Peckitt, C;
Saunders, M;
... Harrington, KJ; + view all
(2018)
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
Clinical and Translational Radiation Oncology
, 12
pp. 16-20.
10.1016/j.ctro.2018.06.001.
|
|
|
Dirix, LY;
Takacs, I;
Jerusalem, G;
Nikolinakos, P;
Arkenau, H-T;
Forero-Torres, A;
Boccia, R;
... Hamilton, EP; + view all
(2018)
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
Breast Cancer Research and Treatment
, 167
(3)
pp. 671-686.
10.1007/s10549-017-4537-5.
|
|
F
|
Forster, M;
Hackshaw, A;
De Pas, T;
Cobo, M;
Garrido, P;
Summers, Y;
Dingemans, AMC;
... Lee, SM; + view all
(2018)
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3).
Lung Cancer
, 120
pp. 27-33.
10.1016/j.lungcan.2018.03.007.
|
|
|
Forster, MD;
Devlin, M-J;
(2018)
Immune Checkpoint Inhibition in Head and Neck Cancer.
Frontiers in Oncology
, 8
, Article 310. 10.3389/fonc.2018.00310.
|
|
|
Forte, N;
Livanos, M;
Miranda, E;
Morais, M;
Yang, X;
Rajkumar, VS;
Chester, KA;
... Baker, JR; + view all
(2018)
Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs.
Bioconjugate Chemistry
, 29
(2)
pp. 486-492.
10.1021/acs.bioconjchem.7b00795.
|
|
G
|
Ghorani, E;
Rosenthal, R;
McGranahan, N;
Reading, JL;
Lynch, M;
Peggs, KS;
Swanton, C;
(2018)
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Annals of Oncology
, 29
(1)
pp. 271-279.
10.1093/annonc/mdx687.
|
|
|
Gillessen, S;
Attard, G;
Beer, TM;
Beltran, H;
Bossi, A;
Bristow, R;
Carver, B;
... Omlin, A; + view all
(2018)
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
European Urology
, 73
(2)
pp. 178-211.
10.1016/j.eururo.2017.06.002.
|
|
Grieco, G;
Janssens, V;
Chevronnay, HPG;
N'Kuli, F;
Van Der Smissen, P;
Wang, T;
Shan, J;
... Courtoy, PJ; + view all
(2018)
Vps34/PI3KC3 deletion in kidney proximal tubules impairs apical trafficking and blocks autophagic flux, causing a Fanconi-like syndrome and renal insufficiency.
Scientific Reports
, 8
, Article 14133. 10.1038/s41598-018-32389-z.
|
|
|
Gurusamy, K;
Corrigan, N;
Croft, J;
Twiddy, M;
Morris, S;
Woodward, N;
Bandula, S;
... Davidson, BR; + view all
(2018)
Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases (LAVA): study protocol for a randomised controlled trial.
Trials
, 19
, Article 105. 10.1186/s13063-018-2499-5.
|
|
H
|
Hainsworth, JD;
Meric-Bernstam, F;
Swanton, C;
Hurwitz, H;
Spigel, DR;
Sweeney, C;
Burris, H;
... Kurzrock, R; + view all
(2018)
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.
Journal of Clinical Oncology
, 36
(6)
pp. 536-544.
10.1200/JCO.2017.75.3780.
|
|
|
Hartley, JA;
Flynn, MJ;
Bingham, JP;
Corbett, S;
Reinert, H;
Tiberghien, A;
Masterson, LA;
... Howard, PW; + view all
(2018)
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine.
Scientific Reports
, 8
, Article 10479. 10.1038/s41598-018-28533-4.
|
|
|
Harvey, RD;
Aransay, NR;
Isambert, N;
Lee, J-S;
Arkenau, T;
Vansteenkiste, J;
Dickinson, PA;
... Vishwanathan, K; + view all
(2018)
Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin.
British Journal of Clinical Pharmacology
, 84
(12)
pp. 2877-2888.
10.1111/bcp.13753.
|
|
Hellmann, MD;
Nathanson, T;
Rizvi, H;
Creelan, BC;
Sanchez-Vega, F;
Ahuja, A;
Ni, A;
... Wolchok, JD; + view all
(2018)
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
Cancer Cell
, 33
(5)
843-852.e4.
10.1016/j.ccell.2018.03.018.
|
|
|
Holme, H;
Gulati, A;
Brough, R;
Fleuren, EDG;
Bajrami, I;
Campbell, J;
Chong, IY;
... Lord, CJ; + view all
(2018)
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness.
Scientific Reports
, 8
, Article 10614. 10.1038/s41598-018-29043-z.
|
|
|
Howie, AJ;
(2018)
Genetic studies of focal segmental glomerulosclerosis: a waste of scientific time?
Pediatric Nephrology
10.1007/s00467-018-4161-6.
(In press).
|
|
|
Hudson, A;
Chan, C;
Woolf, D;
McWilliam, A;
Hiley, C;
O'Connor, J;
Bayman, N;
... Faivre-Finn, C; + view all
(2018)
Is heterogeneity in stage 3 non-small cell lung cancer obscuring the potential benefits of dose-escalated concurrent chemo-radiotherapy in clinical trials?
Lung Cancer
, 118
pp. 139-147.
10.1016/j.lungcan.2018.02.006.
|
|
Hynds, RE;
Ben Aissa, A;
Gowers, KHC;
Watkins, TBK;
Bosshard-Carter, L;
Rowan, AJ;
Veeriah, S;
... Janes, SM; + view all
(2018)
Expansion of airway basal epithelial cells from primary human non-small cell lung cancer tumors.
International Journal of Cancer
, 143
(1)
pp. 160-166.
10.1002/ijc.31383.
|
|
|
Hynds, RE;
Gowers, KHC;
Nigro, E;
Butler, CR;
Bonfanti, P;
Giangreco, A;
Prele, CM;
(2018)
Cross-talk between human airway epithelial cells and 3T3-J2 feeder cells involves partial activation of human MET by murine HGF.
PLoS ONE
, 13
(5)
, Article e0197129. 10.1371/journal.pone.0197129.
|
|
|
Hynds, RE;
Vladimirou, E;
Janes, SM;
(2018)
The secret lives of cancer cell lines.
[Editorial comment].
Disease Models and Mechanisms
, 11
, Article dmm037366. 10.1242/dmm.037366.
|
|
J
|
Jayaram, A;
Wetterskog, K;
Attard, G;
(2018)
Plasma DNA and Metastatic Castration-Resistant Prostate Cancer: The Odyssey to a Clinical Biomarker Test.
Cancer Discovery
, 8
(4)
pp. 392-294.
10.1158/2159-8290.CD-18-0124.
|
|
Jepson, M;
Elliott, D;
Conefrey, C;
Wade, J;
Rooshenas, L;
Wilson, C;
Beard, D;
... OPTIMA prelim study group, .; + view all
(2018)
An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment.
Journal of Clinical Epidemiology
, 99
pp. 75-83.
10.1016/j.jclinepi.2018.02.018.
|
|
K
|
Kiakos, K;
Englinger, B;
Yanow, SK;
Wernitznig, D;
Jakupec, MA;
Berger, W;
Keppler, BK;
... Patil, PC; + view all
(2018)
Design, synthesis, nuclear localization, and biological activity of a fluorescent duocarmycin analog, HxTfA.
Bioorganic & Medicinal Chemistry Letters
, 28
(8)
pp. 1342-1347.
10.1016/j.bmcl.2018.03.016.
|
|
Koch, C;
Schwing, AM;
Herrmann, E;
Borner, M;
Diaz-Rubio, E;
Dotan, E;
Feliu, J;
... Trojan, J; + view all
(2018)
Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer: an individual patient data based meta-analysis.
Oncotarget
, 9
(12)
pp. 10272-10283.
10.18632/oncotarget.23475.
|
|
|
Krol, I;
Castro-Giner, F;
Maurer, M;
Gkountela, S;
Szczerba, BM;
Scherrer, R;
Coleman, N;
... Aceto, N; + view all
(2018)
Detection of circulating tumour cell clusters in human glioblastoma.
British Journal of Cancer
, 119
pp. 487-491.
10.1038/s41416-018-0186-7.
|
|
L
|
Laurent, P-A;
Hechler, B;
Solinhac, R;
Ragab, A;
Cabou, C;
Anquetil, T;
Severin, S;
... Gratacap, M-P; + view all
(2018)
Impact of PI3K (Phosphoinositide 3-Kinase Alpha) Inhibition on Hemostasis and Thrombosis.
Arteriosclerosis, Thrombosis, and Vascular Biology
, 38
(9)
pp. 2041-2053.
10.1161/ATVBAHA.118.311410.
|
|
Lawler, M;
Alsina, D;
Adams, RA;
Anderson, AS;
Brown, G;
Fearnhead, NS;
Fenwick, SW;
... Tomlinson, I; + view all
(2018)
Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
GUT
, 67
(1)
pp. 179-193.
10.1136/gutjnl-2017-315333.
|
|
|
Lechner, M;
Chakravarthy, AR;
Walter, V;
Masterson, L;
Feber, A;
Jay, A;
Weinberger, PM;
... Fenton, TR; + view all
(2018)
Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
Oral Oncology
, 83
pp. 32-37.
10.1016/j.oraloncology.2018.06.006.
|
|
Lechner, M;
Vassie, C;
Kavasogullari, C;
Jones, O;
Howard, J;
Masterson, L;
Fenton, T;
... Gilson, R; + view all
(2018)
A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK.
BMJ Open
, 8
(7)
, Article e023339. 10.1136/bmjopen-2018-023339.
|
|
|
Linch, M;
Attard, G;
(2018)
Prostate cancers that `Wnt' respond to abiraterone.
Annals of Oncology
, 29
(2)
pp. 290-292.
10.1093/annonc/mdx785.
|
|
Lindsay, CR;
Jamal-Hanjani, M;
Forster, M;
Blackhall, F;
(2018)
KRAS: Reasons for optimism in lung cancer.
European Journal of Cancer
, 99
pp. 20-27.
10.1016/j.ejca.2018.05.001.
|
|
Liu, B;
Pett, L;
Kiakos, K;
Patil, PC;
Satam, V;
Hartley, JA;
Lee, M;
(2018)
DNA-binding properties of new fluorescent AzaHx-amides: Methoxy-pyridyl-aza-benzimidazole-pyrrole-imidazole/pyrrole.
ChemBioChem
, 19
(18)
pp. 1979-1987.
10.1002/cbic.201800273.
|
|
Loveday, C;
Law, P;
Litchfield, K;
Levy, M;
Holroyd, A;
Broderick, P;
Kote-Jarai, Z;
... Turnbull, C; + view all
(2018)
Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology.
European Urology
, 74
(3)
pp. 248-252.
10.1016/j.eururo.2018.05.036.
|
|
|
Loveday, C;
Litchfield, K;
Levy, M;
Holroyd, A;
Broderick, P;
Kote-Jarai, Z;
Dunning, AM;
... Turnbull, C; + view all
(2018)
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer.
Oncotarget
, 9
(16)
pp. 12630-12638.
10.18632/oncotarget.23117.
|
|
Luo, J;
Attard, G;
Balk, SP;
Bevan, C;
Burnstein, K;
Cato, L;
Cherkasov, A;
... Raj, GV; + view all
(2018)
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.
European Urology
, 73
(5)
pp. 715-723.
10.1016/j.eururo.2017.11.038.
|
M
|
Mackay, HL;
Moore, D;
Hall, C;
Birkbak, NJ;
Jamal-Hanjani, M;
Karim, SA;
Phatak, VM;
... Muller, PAJ; + view all
(2018)
Genomic instability in mutant p53 cancer cells upon entotic engulfment.
Nature Communications
, 9
, Article 3070. 10.1038/s41467-018-05368-1.
|
|
|
Madsen, RR;
Vanhaesebroeck, B;
Semple, RK;
(2018)
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders.
Trends in Molecular Medicine
, 24
(10)
10.1016/j.molmed.2018.08.003.
|
|
|
Maher, GJ;
Ralph, HK;
Ding, Z;
Koelling, N;
Mlcochova, H;
Giannoulatou, E;
Dhami, P;
... Goriely, A; + view all
(2018)
Selfish mutations dysregulating RAS-MAPK signaling are pervasive in aged human testes.
Genome Research
, 28
(12)
pp. 1779-1790.
10.1101/gr.239186.118.
|
|
|
Mateo, J;
Chakravarty, D;
Dienstmann, R;
Jezdic, S;
Gonzalez-Perez, A;
Lopez-Bigas, N;
Ng, CKY;
... Pusztai, L; + view all
(2018)
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Annals of Oncology
, 29
(9)
pp. 1895-1902.
10.1093/annonc/mdy263.
|
|
|
Mathew, NR;
Baumgartner, F;
Braun, L;
O'Sullivan, D;
Thomas, S;
Waterhouse, M;
Mueller, TA;
... Zeiser, R; + view all
(2018)
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
Nature Medicine
, 24
(3)
pp. 282-291.
10.1038/nm.4484.
|
|
Mitchell, TJ;
Turajlic, S;
Rowan, A;
Nicol, D;
Farmery, JHR;
O'Brien, T;
Martincorena, I;
... Campbell, PJ; + view all
(2018)
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.
Cell
, 173
(3)
, Article e17. 10.1016/j.cell.2018.02.020.
|
|
|
Monypenny, J;
Milewicz, H;
Flores-Borja, F;
Weitsman, G;
Cheung, A;
Chowdhury, R;
Burgoyne, T;
... Ng, T; + view all
(2018)
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation.
Cell Reports
, 24
(3)
pp. 630-641.
10.1016/j.celrep.2018.06.066.
|
|
|
Muliaditan, T;
Caron, J;
Okesola, M;
Opzoomer, JW;
Kosti, P;
Georgouli, M;
Gordon, P;
... Arnold, JN; + view all
(2018)
Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis.
Nature Communications
, 9
, Article 2951. 10.1038/s41467-018-05346-7.
|
|
P
|
Palam, LR;
Mali, RS;
Ramdas, B;
Srivatsan, SN;
Visconte, V;
Tiu, RV;
Vanhaesebroeck, B;
... Kapur, R; + view all
(2018)
Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway.
JCI Insight
, 3
(4)
, Article e94679. 10.1172/jci.insight.94679.
|
|
|
Palmer, DH;
Ma, YT;
Peck-Radosavljevic, M;
Ross, P;
Graham, J;
Fartoux, L;
Deptala, A;
... Meyer, T; + view all
(2018)
A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma.
British Journal of Cancer
, 118
pp. 1162-1168.
10.1038/s41416-018-0051-8.
|
|
Papoutsaki, M;
Sidhu, H;
Dikaios, N;
Atkinson, D;
Beale, T;
Morley, S;
Forster, M;
... Punwani, S; + view all
(2018)
Pre-treatment intra- and inter- voxel magnetic resonance diffusion heterogeneity correlates with chemoradiotherapy treatment outcome of patients with head and neck squamous cell carcinoma.
Presented at: Joint Annual Meeting ISMRM-ESMRMB 2018, Paris, France.
(In press).
|
|
Parker, CC;
James, ND;
Brawley, CD;
Clarke, NW;
Hoyle, AP;
Ali, A;
Ritchie, AWS;
... Systemic Therapy for Advanced or Metastatic Prostate cancer, .; + view all
(2018)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
, 392
(10162)
pp. 2353-2366.
10.1016/S0140-6736(18)32486-3.
|
|
|
Parker, H;
McIver-Brown, NR;
Davis, ZA;
Parry, M;
Rose-Zerilli, MJJ;
Xochelli, A;
Gibson, J;
... Oscier, DG; + view all
(2018)
CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up.
Blood Advances
, 2
(10)
pp. 1116-1119.
10.1182/bloodadvances.2018019760.
|
|
|
Parry, M;
(2018)
Introducing the Metastatic Breast Cancer Project: a novel patient-partnered initiative to accelerate understanding of MBC.
ESMO Open
, 3
(7)
, Article e000452. 10.1136/esmoopen-2018-000452.
|
|
|
Parry, M;
(2018)
Tumor evolution in non-small-cell lung cancer.
ESMO Open
, 3
(6)
, Article e000436. 10.1136/esmoopen-2018-000436.
|
|
|
Patel, VB;
Zhabyeyev, P;
Chen, X;
Wang, F;
Paul, M;
Fan, D;
McLean, BA;
... Oudit, GY; + view all
(2018)
PI3Kα-regulated gelsolin activity is a critical determinant of cardiac cytoskeletal remodeling and heart disease.
Nature Communications
, 9
(1)
, Article 5390. 10.1038/s41467-018-07812-8.
|
|
|
Peix, L;
Evans, IC;
Pearce, DR;
Simpson, JK;
Maher, TM;
McAnulty, RJ;
(2018)
Diverse functions of clusterin promote and protect against the development of pulmonary fibrosis.
Scientific Reports
, 8
, Article 1906. 10.1038/s41598-018-20316-1.
|
R
|
Reading, JL;
Gálvez-Cancino, F;
Swanton, RC;
Lladser, A;
Peggs, K;
Quezada, S;
(2018)
The function and dysfunction of memory CD8+ T cells in tumor immunity.
Immunological Reviews
, 283
(1)
pp. 194-212.
10.1111/imr.12657.
|
|
Reichold, M;
Klootwijk, ED;
Reinders, J;
Otto, EA;
Milani, M;
Broeker, C;
Laing, C;
... Kleta, R; + view all
(2018)
Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure.
Journal of the American Society of Nephrology
, 29
(7)
pp. 1849-1858.
10.1681/ASN.2017111179.
|
|
|
Rizzo, FM;
Meyer, T;
(2018)
Liquid Biopsies for Neuroendocrine Tumors: Circulating Tumor Cells, DNA, and MicroRNAs.
Endocrinology and Metabolism Clinics of North America
, 47
(3)
pp. 471-483.
10.1016/j.ecl.2018.04.002.
|
|
Romero-Laorden, N;
Lozano, R;
Jayaram, A;
López-Campos, F;
Saez, MI;
Montesa, A;
Gutierrez-Pecharoman, A;
... Olmos, D; + view all
(2018)
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study).
British Journal of Cancer
, 119
(9)
pp. 1052-1059.
10.1038/s41416-018-0123-9.
|
|
S
|
Sage, E;
Davies, A;
Kolluri, K;
Patrick, S;
Weil, B;
Rego, RVTP;
Edwards, A;
... Janes, SM; + view all
(2018)
Targeted stem cells expressing TRAIL as a therapy for lung Cancer TACTICAL: a phase I/II trial.
Lung Cancer
, 115
(Supp. 1)
S87-S87.
10.1016/S0169-5002(18)30222-8.
|
|
Salazar, R;
Garcia-Carbonero, R;
Libutti, SK;
Hendifar, AE;
Custodio, A;
Guimbaud, R;
Lombard-Bohas, C;
... Yao, JC; + view all
(2018)
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors.
The Oncologist
, 23
(7)
766-e90.
10.1634/theoncologist.2017-0144.
|
|
Sansregret, L;
Vanhaesebroeck, B;
Swanton, C;
(2018)
Determinants and clinical implications of chromosomal instability in cancer.
Nature Reviews Clinical Oncology
, 15
(3)
pp. 139-150.
10.1038/nrclinonc.2017.198.
|
|
Scher, HI;
Graf, RP;
Schreiber, NA;
Jayaram, A;
Winquist, E;
McLaughlin, B;
Lu, D;
... Heller, G; + view all
(2018)
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer.
JAMA Oncology
, 4
(9)
pp. 1179-1186.
10.1001/jamaoncol.2018.1621.
|
|
Schöffski, P;
Sufliarsky, J;
Gelderblom, H;
Blay, J-Y;
Strauss, SJ;
Stacchiotti, S;
Rutkowski, P;
... Wozniak, A; + view all
(2018)
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
Lancet Respir Med
, 6
(6)
pp. 431-441.
10.1016/S2213-2600(18)30116-4.
|
|
|
Schöffski, P;
Wozniak, A;
Kasper, B;
Aamdal, S;
Leahy, MG;
Rutkowski, P;
Bauer, S;
... Stacchiotti, S; + view all
(2018)
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.
Annals of Oncology
, 29
(3)
pp. 758-765.
10.1093/annonc/mdx774.
|
|
Schöffski, P;
Wozniak, A;
Leahy, MG;
Aamdal, S;
Rutkowski, P;
Bauer, S;
Richter, S;
... Strauss, SJ; + view all
(2018)
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'.
European Journal of Cancer
, 94
pp. 156-167.
10.1016/j.ejca.2018.02.011.
|
|
Semple, RK;
Vanhaesebroeck, B;
(2018)
Cancer drug tackles overgrowth syndrome.
Nature
, 558
(7711)
pp. 522-525.
|
|
Shapiro, GI;
Kristeleit, RS;
Burris, HA;
LoRusso, P;
Patel, MR;
Drew, Y;
Giordano, H;
... Xiao, JJ; + view all
(2018)
Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors.
Clinical Pharmacology in Drug Development
10.1002/cpdd.575.
(In press).
|
|
|
Strauss, SJ;
Anninga, J;
Baglio, R;
Baumhoer, D;
Behjati, S;
Bielack, S;
Boye, K;
... Whelan, J; + view all
(2018)
Report from the 4th European Bone Sarcoma Networking meeting: focus on osteosarcoma.
Clinical Sarcoma Research
, 8
, Article 17. 10.1186/s13569-018-0103-0.
|
|
|
Strauss, SJ;
Whelan, JS;
(2018)
Current questions in bone sarcomas.
Current Opinion in Oncology
, 30
(4)
pp. 252-259.
10.1097/CCO.0000000000000456.
|
|
Suman, M;
Sharpe, JA;
Bentham, RB;
Kotiadis, VN;
Menegollo, M;
Pignataro, V;
Molgó, J;
... Szabadkai, G; + view all
(2018)
Inositol Trisphosphate Receptor Mediated Ca2+ Signalling Stimulates Mitochondrial Function and Gene Expression in Core Myopathy Patients.
Human Molecular Genetics
, 27
(13)
pp. 2367-2382.
10.1093/hmg/ddy149.
|
|
Sumanasuriya, S;
Omlin, A;
Armstrong, A;
Attard, G;
Chi, KN;
Bevan, CL;
Shibakawa, A;
... de Bono, JS; + view all
(2018)
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.
European Urology Oncology
, 1
(2)
pp. 151-159.
10.1016/j.euo.2018.02.009.
|
|
|
Sydes, MR;
(2018)
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.
Annals Of Oncology
, 29
(5)
pp. 1235-1248.
10.1093/annonc/mdy072.
|
|
T
|
Tan, MP;
Attard, G;
Huddart, RA;
(2018)
Circulating Tumour DNA in Muscle-Invasive Bladder Cancer.
International Journal of Molecular Sciences
, 19
(9)
, Article 2568. 10.3390/ijms19092568.
|
|
|
Turajlic, S;
Swanton, C;
Boshoff, C;
(2018)
Kidney cancer: The next decade.
Journal of Experimental Medicine
, 215
(9)
10.1084/jem.20181617.
|
|
|
Turajlic, S;
Xu, H;
Litchfield, K;
Rowan, A;
Chambers, T;
Lopez, JI;
Nicol, D;
... Swanton, C; + view all
(2018)
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.
Cell
, 173
(3)
581-594.e12.
10.1016/j.cell.2018.03.057.
|
|
|
Turajlic, S;
Xu, H;
Litchfield, K;
Rowan, A;
Horswell, S;
Chambers, T;
O'Brien, T;
... TRACERx Renal Consortium, .; + view all
(2018)
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.
Cell
, 173
(3)
595-610.e11.
10.1016/j.cell.2018.03.043.
|
|
U
|
Uccello, M;
Moschetta, M;
Mak, G;
Alam, T;
Henriquez, CM;
Arkenau, H-T;
(2018)
Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA).
Current Oncology
, 25
(1)
e90-e94.
10.3747/co.25.3708.
|
|
V
|
Vargas, FA;
Furness, AJS;
Litchfield, K;
Joshi, K;
Rosenthal, R;
Ghorani, E;
Solomon, I;
... Quezada, SA; + view all
(2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Cancer Cell
, 33
(4)
pp. 649-663.
10.1016/j.ccell.2018.02.010.
|
|
|
Vena, F;
Jia, R;
Estandian, A;
Garcia-Gomez, JJ;
Rodriguez-Justo, M;
MA, J;
Syed, S;
... Hochhauser, D; + view all
(2018)
MEK inhibition leads to BRCA2 downregulation and sensitization to DNA damaging agents in pancreas and ovarian cancer models.
Oncotarget
, 9
(14)
pp. 11592-11603.
10.18632/oncotarget.24294.
|
|
|
Venkatesan, S;
Rosenthal, R;
Kanu, N;
McGranahan, N;
Bartek, J;
Quezada, SA;
Hare, J;
... Swanton, C; + view all
(2018)
APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.
Annals of Oncology
, 29
(3)
pp. 563-572.
10.1093/annonc/mdy003.
|
|
|
Vesely, C;
Childs, A;
Wong, YNS;
Ogunbiyi, O;
Gander, A;
Luong, T;
Thirlwell, C;
... Meyer, T; + view all
(2018)
Systematic Evaluation of the Immune Microenvironment of Neuroendocrine Tumors (NET).
Presented at: 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain.
|
|
Vogel, A;
Cervantes, A;
Chau, I;
Daniele, B;
Llovet, J;
Meyer, T;
Nault, J-C;
... Martinelli, E; + view all
(2018)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology
, 29
(4)
iv238-iv255.
10.1093/annonc/mdy308.
|
|
W
|
Wedge, DC;
Gundem, G;
Mitchell, T;
Woodcock, DJ;
Martincorena, I;
Ghori, M;
Zamora, J;
... Eeles, RA; + view all
(2018)
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
Nature Genetics
, 50
(5)
pp. 682-692.
10.1038/s41588-018-0086-z.
|
|
Wicki, A;
Brown, N;
Xyrafas, A;
Bize, V;
Hawle, H;
Berardi, S;
Cmiljanović, N;
... Kristeleit, R; + view all
(2018)
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13).
European Journal of Cancer
, 96
pp. 6-16.
10.1016/j.ejca.2018.03.012.
|
|
Wong, YNS;
Joshi, K;
Khetrapal, P;
Ismail, M;
Reading, JL;
Sunderland, MW;
Georgiou, A;
... Quezada, SA; + view all
(2018)
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment.
Journal of Experimental Medicine
, 215
(11)
pp. 2748-2759.
10.1084/jem.20181003.
|
|
|
Woods, BS;
Sideris, E;
Sydes, MR;
Gannon, MR;
Parmar, MKB;
Alzouebi, M;
Attard, G;
... Sculpher, MJ; + view all
(2018)
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
European Urology Oncology
, 1
(6)
pp. 449-458.
10.1016/j.euo.2018.06.004.
|
|
|
Worrall, JT;
Tamura, N;
Mazzagatti, A;
Shaikh, N;
van Lingen, T;
Bakker, B;
Spierings, DCJ;
... McClelland, SE; + view all
(2018)
Non-random Mis-segregation of Human Chromosomes.
Cell Reports
, 23
(11)
pp. 3366-3380.
10.1016/j.celrep.2018.05.047.
|
|
|
Wu, C-E;
Esfandiari, A;
Ho, Y-H;
Wang, N;
Mahdi, AK;
Aptullahoglu, E;
Lovat, P;
(2018)
Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
British Journal of Cancer
, 118
(4)
pp. 495-508.
10.1038/bjc.2017.433.
|
|
|
Wu, C-E;
Koay, TS;
Esfandiari, A;
Ho, Y-H;
Lovat, P;
Lunec, J;
(2018)
ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma.
Cancers
, 11
(1)
, Article 3. 10.3390/cancers11010003.
|
|
Z
|
Zammarchi, F;
Corbett, S;
Adams, L;
Tyrer, PC;
Kiakos, K;
Janghra, N;
Marafioti, T;
... van Berkel, PH; + view all
(2018)
ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignancies.
Blood
, 131
(10)
pp. 1094-1105.
10.1182/blood-2017-10-813493.
|
